Advertisement
Mechanical stimuli induce cleavage and nuclear translocation of the polycystin-1 C terminus
Veronique Chauvet, Xin Tian, Herve Husson, David H. Grimm, Tong Wang, Thomas Hieseberger, Peter Igarashi, Anton M. Bennett, Oxana Ibraghimov-Beskrovnaya, Stefan Somlo, and Michael J. Caplan
Find articles by Chauvet, V. in: JCI | PubMed | Google Scholar
Find articles by Tian, X. in: JCI | PubMed | Google Scholar
Find articles by Husson, H. in: JCI | PubMed | Google Scholar
Find articles by Grimm, D. in: JCI | PubMed | Google Scholar
Find articles by Wang, T. in: JCI | PubMed | Google Scholar
Find articles by Hieseberger, T. in: JCI | PubMed | Google Scholar
Find articles by Igarashi, P. in: JCI | PubMed | Google Scholar
Find articles by Bennett, A. in: JCI | PubMed | Google Scholar
Find articles by Ibraghimov-Beskrovnaya, O. in: JCI | PubMed | Google Scholar
Find articles by Somlo, S. in: JCI | PubMed | Google Scholar
Find articles by Caplan, M. in: JCI | PubMed | Google Scholar
First published March 1, 2005 - More info
J Clin Invest. 2005;115(3):788–788. https://doi.org/10.1172/JCI21753C1.
© 2005 The American Society for Clinical Investigation
Related article:
Abstract
Polycystin-1, which is encoded by a gene that is mutated in autosomal dominant polycystic kidney disease (ADPKD), is involved in cell-matrix interactions as well as in ciliary signaling. The precise mechanisms by which it functions, however, remain unclear. Here we find that polycystin-1 undergoes a proteolytic cleavage that releases its C-terminal tail (CTT), which enters the nucleus and initiates signaling processes. The cleavage occurs in vivo in association with alterations in mechanical stimuli. Polycystin-2, the product of the second gene mutated in ADPKD, modulates the signaling properties of the polycystin-1 CTT. These data reveal a novel pathway by which polycystin-1 transmits messages directly to the nucleus.
Authors
Veronique Chauvet, Xin Tian, Herve Husson, David H. Grimm, Tong Wang, Thomas Hieseberger, Peter Igarashi, Anton M. Bennett, Oxana Ibraghimov-Beskrovnaya, Stefan Somlo, Michael J. Caplan
Original citation: J. Clin. Invest.114:1433–1443(2004). doi:10.1172/JCI21753
Citation for this erratum: J. Clin. Invest.115:788 (2005). doi:10.1172/JCI21480C1
The name of one of the authors, Thomas Hiesberger, was misspelled. The corrected author list is as follows:
Veronique Chauvet, Xin Tian, Herve Husson, David H. Grimm, Tong Wang, Thomas Hiesberger, Peter Igarashi, Anton M. Bennett, Oxana Ibraghimov-Beskrovnaya, Stefan Somlo, and Michael J. Caplan
The authors regret the error.
Copyright © 2019 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)